搜尋結果
Australia to ban knock-offs of popular weight-loss drugs Ozempic, Mounjaro
Reuters· 4 日前Australia said on Wednesday it will ban copies of drugs used for weight loss such as Ozempic and Mounjaro ...
Healthy Returns: Eli Lilly, Novo Nordisk are competing to develop more convenient weekly insulins
CNBC· 4 日前A patient injects herself with an insulin pen. The rivalry between Eli Lilly and Novo ... ...
Eli Lilly stock hits new highs after a regulatory win in China. This is a big deal
CNBC· 4 日前Every weekday the CNBC Investing Club with Jim Cramer holds a "Morning Meeting" ...
JPMorgan says there's a new GLP-1 drug player and its shares can rally 80%
CNBC· 4 日前Structure Therapeutics is an overlooked player in the GLP-1 market, and could one ...
US FDA staff says Guardant's test may fail to detect some pre-cancerous tumors
Reuters· 4 日前, opens new tab experimental blood test for a cancer of colon or rectum may fail to detect some ...
Nestle set to sell $5 pizza, sandwiches for Wegovy, Ozempic users
Reuters· 4 日前, opens new tab will market a new, $5 line of frozen pizzas and protein-enriched pastas ... ...
Nestle to launch Vital Pursuit frozen-food brand targeting GLP-1 users
CNBC· 4 日前Nestle is launching a new frozen-food brand, Vital Pursuit, aimed at the growing & ...
China Clears Eli Lilly’s Weight-Loss Drug, Only for Diabetes Now
Bloomberg· 5 日前Have a confidential tip for our reporters? China gave the greenlight to Eli Lilly ...
AstraZeneca targets $80 billion in total revenue by 2030 in 'post-Covid era'
CNBC· 5 日前LONDON — Pharmaceutical company AstraZeneca on Tuesday said it planned to increase its total ...
London stocks fall as Fed's cautious stance weighs on sentiment
Reuters· 5 日前London stocks slipped on Tuesday, tracking weakness in Asian markets as U.S. Federal ... ...